FFTY:ARCA-Innovator IBD 50 Fund

ETF | N/A | NYSE Arca

Last Closing Price

Change

0.00 (0.00)%

Market Cap

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

N/A

About

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.

Inception Date: 08/04/2015

Primary Benchmark: IBD 50 Index USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio: 0.80 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
TTD 3.72 %
FIVE 3.71 %
TWTR 3.50 %
NFLX 3.48 %
ALGN 3.47 %
VNOM 3.47 %
GRUB 3.42 %
GOOS:CA 3.40 %
ABMD 3.39 %
LGND 3.30 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: )

Largest Industry Peers for N/A

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs.
Industry/Classification (N/A)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.07B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike

FFTY:ARCA-Innovator IBD 50 Fund

ETF | N/A | NYSE Arca

Last Closing Price

Change

0.00 (0.00)%

Market Cap

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

N/A

Values as of: